Showing papers by "Zygmunt Kazimierczuk published in 2015"
TL;DR: Pharmacological (anticancer) activity of the compounds was evaluated based on their ability to induce apoptosis in exponentially growing cultures of the human acute myelogenous leukemia cell line KG-1; the apoptosis was assessed with a variety of flow cytometric methods.
Abstract: Isothioureas are a class of amphiphilic compounds carrying a highly basic isothiourea group of pKa ranging between 10 and 11. Hence, they exist in protonated (cation) form at physiological pH, a characteristic is of key importance for their pharmacological activity. Recently, we have found that a number of S-pentabromobenzylisothiourea derivatives show substantial cytotoxicity toward a variety of human glioblastoma, leukemia, and adenocarcinoma cell lines. Whereas there is a growing body of data on aliphatic and alkylaromatic isothioureas, little attention was given to this day to heterocyclic isotiourea derivatives. Here we report on the synthesis and pharmacological in vitro properties of 10 novel S-(benzimidazol-2-ylmethyl)- and S-(5,6-dichlorobenzimidazol-2-ylmethyl)isothiourea derivatives. The compounds were obtained by the condensation of the respective 2-chloromethyl benzimidazoles with various substituted N(N’)-thioureas. Besides the essential physicochemical characteristics (H-NMR, UV, elemental analysis) of the new compounds, their log P values, which are of key importance for in vivo drug distribution and interactions, were determined. Pharmacological (anticancer) activity of the compounds was evaluated based on their ability to induce apoptosis in exponentially growing cultures of the human acute myelogenous leukemia cell line KG-1; the apoptosis was assessed with a variety of flow cytometric methods. Of the novel compounds tested, the most potent apoptosis inducer in KG-1 cells was N-methyl-S- (5,6-dichloro-1 H -benzimidazol-2-ylmethyl)isothiouronium chloride (ClBMMe).
12 citations
TL;DR: The crystal structure of 1,4-di(2-phenyl-1H-imidazol-4-yl)benzene (DPI4B) was determined by X-ray diffraction with a final R-factor of 6.42% at room temperature as discussed by the authors.
Abstract: The crystal structure of 1,4-di(2-phenyl-1H-imidazol-4-yl)benzene (DPI4B) is determined by X-ray diffraction with a final R-factor of 6.42% at room temperature. It crystallizes with a space group P21/c, Z = 4, a = 5.01790(10), b = 28.8971(6), and c = 12.9362(3) A; β = 98.757(2)°. Two 4-phenyl-1H-imidazole (4PI) fragments are related by inversion symmetry and each makes a dihedral angle of 0° with the benzene rings. Despite the presence of a total number of five homo- and heterocyclic rings in the DPI4B molecule, similarly to 2-phenyl-1H-imidazole (2PI) but in contrast to 1,4-di(1H-imidazol-4-yl)benzene (DI4B) and 4-phenyl-1H-imidazole (4PI), it is almost planar. Each plane containing a terminal phenyl ring makes a small dihedral angle of about 3° with the central benzene ring plane. The average twisting angle of the whole molecule is equal to 7°. The ordering of compounds studied according to the decreasing twisting angle is 4PI > DI4B > DPI4B > 2PI and is the same as that according to hydrogen bond lengt...
5 citations